Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Meta Platforms (NASDAQ:META) Shares Acquired Sen. Shelley Moore Capito
02:32am, Friday, 05'th Dec 2025
Senator Shelley Moore Capito (R-West Virginia) recently bought shares of Meta Platforms, Inc. (NASDAQ: META). In a filing disclosed on December 04th, the Senator disclosed that they had bought between
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026
02:30am, Friday, 05'th Dec 2025
Meta Platforms generates high cash flow and can afford to take risks on AI spending. ASML's lithography machines are essential for manufacturing advanced AI chips.
Sen. Shelley Moore Capito Sells Lowe’s Companies, Inc. (NYSE:LOW) Stock
02:02am, Friday, 05'th Dec 2025
Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Lowe's Companies, Inc. (NYSE: LOW). In a filing disclosed on December 04th, the Senator disclosed that they had sold between $1,0
Market Today: WBD Sale Bids, Meta Cuts, Apple Shake-Up
05:33pm, Thursday, 04'th Dec 2025
Stock News WBD sale draws scrutiny as Netflix leads: Warner Bros. Discovery (WBD) received second-round offers with Netflix (NFLX) reportedly the leading bidder
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
10:31am, Thursday, 04'th Dec 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.
Companies Cut Prices For Blockbuster Weight-Loss Drugs
03:10pm, Wednesday, 03'rd Dec 2025
In this week's edition of InnovationRx, we look at the price cuts for blockbuster weight-loss drugs, the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more. To get i
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year
01:10pm, Wednesday, 03'rd Dec 2025
Eli Lilly has seen revenue soar thanks to its blockbuster weight loss drug portfolio. Lilly and Novo Nordisk dominate this market, which has seen high demand.
Approval is based on results from the BRUIN CLL-321 trial, the only randomized Phase 3 study in CLL/SLL in which all patients were previously treated with a covalent BTK inhibitor This expanded indica
GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors
10:46am, Wednesday, 03'rd Dec 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Chris Otto brings over three decades of global clinical research experience to the Board of Directors of GXP-Storage.
2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years
06:45am, Wednesday, 03'rd Dec 2025
These two market leaders boast significant growth prospects in their niches. They increased their payouts at a good clip over the past decade.
Market Today: Deal Talks, Retail Wins, AI Chips, and Crypto Volatility
05:34pm, Tuesday, 02'nd Dec 2025
Stock News Dell family's $6.25B pledge to kids' accounts: Dell Technologies (DELL) founder Michael Dell (Trades, Portfolio) and Susan Dell committed $6.25 billi
Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
01:43pm, Tuesday, 02'nd Dec 2025
Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
01:31pm, Tuesday, 02'nd Dec 2025
Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.
Washington, D.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Howard University has received a grant of $10 million from Lilly Endowment Inc. through its Pathways for Tomorrow Initiative. The funding wil
Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple
10:30am, Tuesday, 02'nd Dec 2025
Analysts at Bernstein just reiterated an outperform rating on Apple (
